期刊文献+
共找到5篇文章
< 1 >
每页显示 20 50 100
Chemokine platelet factor 4 accelerates peripheral nerve regeneration by regulating Schwann cell activation and axon elongation 被引量:3
1
作者 Miao Gu Xiao Cheng +3 位作者 Di Zhang Weiyan Wu Yi Cao Jianghong He 《Neural Regeneration Research》 SCIE CAS CSCD 2024年第1期190-195,共6页
Schwann cells in peripheral nerves react to traumatic nerve injury by attempting to grow and regenerate.Howeve r,it is unclear what factors play a role in this process.In this study,we searched a GEO database and foun... Schwann cells in peripheral nerves react to traumatic nerve injury by attempting to grow and regenerate.Howeve r,it is unclear what factors play a role in this process.In this study,we searched a GEO database and found that expression of platelet factor 4 was markedly up-regulated after sciatic nerve injury.Platelet factor is an important molecule in cell apoptosis,diffe rentiation,survival,and proliferation.Further,polymerase chain reaction and immunohistochemical staining confirmed the change in platelet factor 4 in the sciatic nerve at different time points after injury.Enzyme-linked immunosorbent assay confirmed that platelet factor 4 was secreted by Schwann cells.We also found that silencing platelet factor 4 decreased the proliferation and migration of primary cultured Schwann cells,while exogenously applied platelet factor 4 stimulated Schwann cell prolife ration and migration and neuronal axon growth.Furthermore,knocking out platelet factor 4 inhibited the prolife ration of Schwann cells in injured rat sciatic nerve.These findings suggest that Schwann cell-secreted platelet factor 4 may facilitate peripheral nerve repair and regeneration by regulating Schwann cell activation and axon growth.Thus,platelet factor 4 may be a potential therapeutic target for traumatic peripheral nerve injury. 展开更多
关键词 axon elongation bioinformatic analysis cell migration cell proliferation dorsal root ganglia peripheral nerve regeneration peripheral nerve trauma platelet factor 4 rat sciatic nerve Schwann cells
暂未订购
Platelet factor 4 induces bone loss by inhibiting the integrinα5-FAK-ERK pathway 被引量:1
2
作者 Wei Li Qiwei Zhang +2 位作者 Ranli Gu Lijun Zeng Hao Liu 《Animal Models and Experimental Medicine》 CAS CSCD 2023年第6期573-584,共12页
Background:The effect of platelet factor 4(PF4)on bone marrow mesenchymal stem cells(BMMSCs)and osteoporosis is poorly understood.Therefore,this study aimed to evaluate the effects of PF4-triggered bone destruction in... Background:The effect of platelet factor 4(PF4)on bone marrow mesenchymal stem cells(BMMSCs)and osteoporosis is poorly understood.Therefore,this study aimed to evaluate the effects of PF4-triggered bone destruction in mice and determine the underlying mechanism.Methods:First,in vitro cell proliferation and cell cycle of BMMSCs were assessed using a CCK8 assay and flow cytometry,respectively.Osteogenic differentiation was confirmed using staining and quantification of alkaline phosphatase and Alizarin Red S.Next,an osteoporotic mouse model was established by performing bilateral ovariectomy(OVX).Furthermore,the PF4 concentrations were obtained using enzymelinked immunosorbent assay.The bone microarchitecture of the femur was evaluated using microCT and histological analyses.Finally,the key regulators of osteogenesis and pathways were investigated using quantitative real-time polymerase chain reaction and Western blotting.Results:Human PF4 widely and moderately decreased the cell proliferation and osteogenic differentiation ability of BMMSCs.Furthermore,the levels of PF4 in the serum and bone marrow were generally increased,whereas bone microarchitecture deteriorated due to OVX.Moreover,in vivo mouse PF4 supplementation triggered bone deterioration of the femur.In addition,several key regulators of osteogenesis were downregulated,and the integrinα5-focal adhesion kinase-extracellular signalregulated kinase(ITGA5-FAK-ERK)pathway was inhibited due to PF4 supplementation.Conclusions:PF4 may be attributed to OVX-i nduced bone loss triggered by the suppression of bone formation in vivo and alleviate BMMSC osteogenic differentiation by inhibiting the ITGA5-FAK-ERK pathway. 展开更多
关键词 bone loss bone marrow mesenchymal stem cells integrinα5 OSTEOGENESIS platelet factor 4
暂未订购
Effects of Platelet Factor 4 on Expression of Bone Marrow Heparan Sulfate in Syngenic Bone Marrow Transplantation Mice
3
作者 孟凡凯 孙汉英 +5 位作者 刘文励 袁慧玲 徐惠珍 孙岚 周银莉 任天华 《Journal of Huazhong University of Science and Technology(Medical Sciences)》 SCIE CAS 2002年第3期190-192,共3页
To explore the effects of platelet factor 4(PF4) on hematopoietic reconstitution and its mechanism in syngenic bone marrow transplantation (BMT). The syngenic B MT mice models were established. 20 and 26 h before irr... To explore the effects of platelet factor 4(PF4) on hematopoietic reconstitution and its mechanism in syngenic bone marrow transplantation (BMT). The syngenic B MT mice models were established. 20 and 26 h before irradiation, the mice were injected 20 μg/kg PF4 or PBS twice into abdominal cavity, then the donor bone marrow nuclear cells (BMNC) were transplanted. On the 7th day, spleen clone forming units (CFU S) were counted. On the 7th, 14th and 21st day after BMT, the BMNC and megakaryoryocytes in bone marrow tissue were counted and the percentage of hematopoietic tissue and expression level of heparan sulfate in bone marrow tissue were assessed. In PF4 treated groups, the CFU S counts on the 7th day were higher than those in BMT groups after BMT. The BMNC and megakaryoryocyte counts and the percentage of hematopoietic tissue and heparan sulfate expression level were higher than those in BMT group on the 7th, 14th and 21st day after BMT ( P <0.01 or P <0.05). PF4 could accelerate hematopoietic reconstitution of syngenic bone marrow transplantation. The promotion of the heparan sulfate expression in bone marrow may be one of mechanisms of PF4. 展开更多
关键词 platelet factor 4 bone marrow transplantation heparan sulfate
暂未订购
人血小板因子4在大肠杆菌中的高效表达及活性研究 被引量:3
4
作者 张俊芳 韩兵社 +3 位作者 解军 胡晓年 牛勃 程牛亮 《中国生物工程杂志》 CAS CSCD 2004年第5期73-77,共5页
为了提高人血小板因子 4(humanplateletfactor 4,hPF4)的表达 ,在PT7 7 hPF4表达质粒的基础上 ,采用PCR定位突变技术 ,改造人血小板因子 4(hPF4)cDNA基因片段 ,去除cDNA 3′端非翻译区AT富含序列 ,改用大肠杆菌强串联终止密码子TAATAA ... 为了提高人血小板因子 4(humanplateletfactor 4,hPF4)的表达 ,在PT7 7 hPF4表达质粒的基础上 ,采用PCR定位突变技术 ,改造人血小板因子 4(hPF4)cDNA基因片段 ,去除cDNA 3′端非翻译区AT富含序列 ,改用大肠杆菌强串联终止密码子TAATAA ,成功构建了高效表达质粒pBV2 2 0 hPF4。摇瓶发酵重组人血小板因子 4的产量达 1 60mg L较原表达质粒PT7 7 hPF4表达量提高了近 80倍。经包涵体的洗涤、变性、复性后 ,采用鸡胚绒毛尿囊膜血管生成抑制实验测定复性后rhPF4的生物学活性 ,结果显示 :rhPF4具有抑制血管生成活性。 展开更多
关键词 人血小板因子4 大肠杆菌 表达 活性 质粒 血管生成抑制
在线阅读 下载PDF
血小板第四因子对CD34^+白血病细胞系KG1a粘附功能的影响
5
作者 张晶 马月霞 韩忠朝 《中国医学科学院学报》 CAS CSCD 北大核心 2002年第2期160-164,共5页
目的研究血小板第四因子(PF4)对CD34+白血病细胞系KG1a细胞与人脐静脉内皮细胞系ECV-304细胞之间粘附性及对多种粘附分子表达的影响。方法采用粘附实验、粘附阻断实验、MTT染色、半定量RT-PCR、免疫标记流式细胞仪测定等方法。结果穴1雪... 目的研究血小板第四因子(PF4)对CD34+白血病细胞系KG1a细胞与人脐静脉内皮细胞系ECV-304细胞之间粘附性及对多种粘附分子表达的影响。方法采用粘附实验、粘附阻断实验、MTT染色、半定量RT-PCR、免疫标记流式细胞仪测定等方法。结果穴1雪PF4可以增加KG1a细胞与ECV-304细胞之间的粘附作用。PF4与KG1a及ECV-304细胞同时孵育或与KG1a或ECV-304细胞单独孵育,均使KG1a细胞粘附能力增加。穴2雪抗粘附分子CD49d、CD106、CD54单克隆抗体可显著减少PF4对KG1a粘附的增加作用,而抗粘附分子CD62L、CD62E、CD62P单抗则对PF4的这种增加粘附的作用没有影响。穴3雪在PF4作用的3h内,半定量RT-PCR检测粘附分子CD49d、CD106、CD54mRNA表达水平有不同程度的上调。(4)PF4作用2h后,流式细胞仪分析显示KG1a细胞上的CD49d、ECV-304细胞上的CD54蛋白表达水平显著增加。结论PF4通过上调粘附分子的表达促进KG1a细胞的粘附功能。 展开更多
关键词 血小板第四因子 KG1a细胞系 ECV-304细胞系 粘附 CD34^+白血病细胞系 影响
暂未订购
上一页 1 下一页 到第
使用帮助 返回顶部